| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 10/14/2004 | CA2521056A1 Hydrazone derivative |
| 10/14/2004 | CA2520930A1 Use of the hydrochloride of the active ingredient base 1-[n<sp>2</sp>-[3,5-dibromo-n-[[4-(3,4-dihydro-2(1h)-oxoquinazolin-3-yl)-1-piperidinyl]-carbonyl]-d-tyrosyl]-l-lysyl]-4-(4-pyridinyl)-piperazine combined with sumatriptan for the treatment of migraines |
| 10/14/2004 | CA2520900A1 Pyrrolo[1,2-b]pyridazine compounds and their use as crf1 receptor antagonists |
| 10/14/2004 | CA2520899A1 Pyrrolo[1,2-b]pyridazine compounds and their uses |
| 10/14/2004 | CA2520828A1 Use of 10-hydroxy-10,11-dihydrocarbamazepine derivatives for the treatment of affective disorders |
| 10/14/2004 | CA2520568A1 Indolone-acetamide derivatives, processes for preparing them and their uses |
| 10/14/2004 | CA2520493A1 Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof |
| 10/14/2004 | CA2520423A1 Treatment of demyelinating conditions |
| 10/14/2004 | CA2520281A1 Benzimidazole derivatives and their use for modulating the gabaa recept or complex |
| 10/14/2004 | CA2518913A1 Novel quinoline, tetrahydroquinazoline, and pyrimidine derivatives and methods of treatment related to the use thereof |
| 10/13/2004 | EP1466975A1 Postsynaptic proteins |
| 10/13/2004 | EP1466913A1 Benzoylecgonine, ecgonine and ecgonidine derivatives |
| 10/13/2004 | EP1466904A1 Biaryl compound and use thereof |
| 10/13/2004 | EP1466901A1 Serotonine reuptake inhibitor |
| 10/13/2004 | EP1466889A1 Derivatives of venlafaxine and methods of preparing and using the same |
| 10/13/2004 | EP1466624A1 Drug for regenerating tissue and vessel and method therefor |
| 10/13/2004 | EP1466620A1 Compounds modulating FSHR and therapeutic uses thereof |
| 10/13/2004 | EP1466609A1 Method of preparing and using isoflavones |
| 10/13/2004 | EP1466606A2 Use of inosine for the manufacture of a medicament for stimulating axonal outgrowth of central nervous system neurons |
| 10/13/2004 | EP1466605A2 Calcium channel blockers |
| 10/13/2004 | EP1466604A1 Isoquinoline derivatives, process for their preparation and use thereof in the treatment of melatoninergic system problems |
| 10/13/2004 | EP1466601A2 Prevention of migraine recurrence |
| 10/13/2004 | EP1466178A1 Screening methods and the use of agents identified using the same |
| 10/13/2004 | EP1465997A2 Use of biomolecular targets in the treatment and visualization of tumors |
| 10/13/2004 | EP1465924A2 Modulators of notch ic protease activity for use in immunotherapy |
| 10/13/2004 | EP1465900A1 Rho-kinase inhibitors |
| 10/13/2004 | EP1465893A1 Derivatives of 5-(pyridin-3-yl)-1-azabicyclo (3.2.1) octane, the preparation thereof and the application of same in therapeutics |
| 10/13/2004 | EP1465891A2 Inhibitors of dipeptidyl peptidase iv |
| 10/13/2004 | EP1465886A1 Bipyridinyl derivatives as a highly selective cyclooxygenase-2 inhibitor |
| 10/13/2004 | EP1465880A1 5-sulphanyl-4h-1,2,4-triazole derivatives and their use as medicine |
| 10/13/2004 | EP1465872A1 4-sulfide/sulfoxide/sulfonyl-1h-pyrazolyl derivative compounds, for use in diseases associated with the 5-ht2c receptor |
| 10/13/2004 | EP1465871A1 Pyrazole derivatives for use in diseases associated with the 5-ht2c receptor |
| 10/13/2004 | EP1465870A2 Substituted 4-phenyltetrahydroisoquinolinium salts, method for production and use thereof as a medicament and medicaments comprising the same |
| 10/13/2004 | EP1465869A1 Modulators of lxr |
| 10/13/2004 | EP1465868A1 Phenoxy piperidines for treating diseases such as schizophrenia and depression |
| 10/13/2004 | EP1465867A1 Ligands of melanocortin receptors and compositions and methods related thereto |
| 10/13/2004 | EP1465863A1 Potassium channel modulators |
| 10/13/2004 | EP1465861A1 Alpha-(n-sulphonamido)acetamide derivatives as beta-amyloid inhibitors |
| 10/13/2004 | EP1465659A2 Use of a novel cell surface protease from group b streptococcus |
| 10/13/2004 | EP1465653A1 Therapeutic application of g-csf, gm-csf and scf |
| 10/13/2004 | EP1465649A2 Methods and compositions for derepression of iap-inhibited caspase |
| 10/13/2004 | EP1465635A2 Melanin concentrating hormone receptor ligands: substituted 2-(4-benzyl-piperazin-1-ylmethyl)- and 2-(4-benzyl-diazepan-1-ylmethyl)-1h-benzoimidazole analogues |
| 10/13/2004 | EP1465630A1 Cyclic urea derivatives with 5-ht2c receptor activity |
| 10/13/2004 | EP1465627A1 DOSING REGIMEN FOR PPAR−GAMMA ACTIVATORS |
| 10/13/2004 | EP1465626A2 Pharmaceutical compositions comprising dihydropyridinone compounds and an immunoregulatory or an antiinflammatory agent and their uses |
| 10/13/2004 | EP1465623A1 Urea derivatives |
| 10/13/2004 | EP1465619A1 Suppression of cartilage degradation via the estrogen receptor |
| 10/13/2004 | EP1465617A1 Process for affecting neurologic progression |
| 10/13/2004 | EP1465616A1 Treatment of statin side effects using uridine derivatives |
| 10/13/2004 | EP1465611A2 Composition, synthesis and therapeutic applications of polyamines |
| 10/13/2004 | EP1465609A2 Modulation of dopaminergic neurons |
| 10/13/2004 | EP1465596A1 Polymeric gel system for the controlled delivery of codrugs |
| 10/13/2004 | EP1465563A1 METHOD OF SYSTEMICALLY DELIVERING SSRIs |
| 10/13/2004 | EP1397137A4 Hydantion derivatives as inhibitors of matrix metalloproteinases |
| 10/13/2004 | EP1381615B1 ANTIDEPRESSANT INDOLETETRAHYDROPYRIDINE DERIVATIVES OF 2,3-DIHYDRO-7H- [1,4]DIOXINO[2,3-e]INDOLE |
| 10/13/2004 | EP1381613B1 Antidepressant azaheterocyclylmethyl derivatives of oxaheterocycle-fused-(1,4)-benzodioxans |
| 10/13/2004 | EP1361897A4 Methods for inhibiting pain |
| 10/13/2004 | EP1322309A4 High affinity small molecule c5a receptor modulators |
| 10/13/2004 | EP1313510B1 Injectable pharmaceutical composition for systemic delivery of pharmacologically active compounds comprising medium chain triglycerides |
| 10/13/2004 | EP1280820B1 Anti-inflammatory compounds and uses thereof |
| 10/13/2004 | EP1257584B1 Humanized antibodies that sequester amyloid beta peptide |
| 10/13/2004 | EP1211253B1 Tricyclic dihydrobenzofuran derivatives, process for the preparation thereof and agents |
| 10/13/2004 | EP1207866B1 Delayed-action form of administration containing tramadol saccharinate |
| 10/13/2004 | EP1202965B1 Indole derivatives, processes for their preparation, pharmaceutical compositions containing them and their medicinal application |
| 10/13/2004 | EP1202628B1 Novel hypoxanthine and thiohypoxanthine compounds |
| 10/13/2004 | EP1200151B1 Drug delivery device for insertion into the vagina, rectum or nasal cavity |
| 10/13/2004 | EP1169038A4 Cyclic protein tyrosine kinase inhibitors |
| 10/13/2004 | EP1150954B1 Anti-imflammatory indole derivatives |
| 10/13/2004 | EP1135166B1 Hapten-carrier conjugates for treating and preventing nicotine addiction |
| 10/13/2004 | EP1131340B1 Hexapeptide with the stabilized disulfide bond and derivatives thereof regulating metabolism, proliferation, differentiation and apoptosis |
| 10/13/2004 | EP1107746B1 Methods of using and compositions comprising dopamine reuptake inhibitors |
| 10/13/2004 | EP1107745B1 Use of 5ht-6 antagonists for the treatment of adhd |
| 10/13/2004 | EP1093366B1 Pharmaceutical composition containing gaba analogs and an antiviral agent to treat shingles |
| 10/13/2004 | EP1086086B1 Imidazolyl derivatives and their use as somatostatin receptor ligands |
| 10/13/2004 | EP0986389B1 Novel process |
| 10/13/2004 | EP0840616B1 Soluble lymphotoxin-beta receptors and anti-lymphotoxin receptor and ligand antibodies, as therapeutic agents for the treatment of immunological diseases |
| 10/13/2004 | EP0802912B1 Piperidine derivatives having tachykinin antagonist activity |
| 10/13/2004 | CN1537115A C2,5'-disubstituted and N6, C2, 5' trisubstituted adenosine derivatives and their different uses |
| 10/13/2004 | CN1537113A Process for production of N-[3-(3-cyanopyrazolo[1,5-a]pyrimidin-7-yl)phenyl]-N-ethylacetamide (zaleplom) |
| 10/13/2004 | CN1537112A Pyrimidine compound |
| 10/13/2004 | CN1537111A Urea substituted imidazoquinolines |
| 10/13/2004 | CN1537105A Quinazolines as MMP-13 inhibitors |
| 10/13/2004 | CN1537102A Ortho-substituted nitrogen-containing bisaryl compounds used as potassium channel inhibitors |
| 10/13/2004 | CN1537100A Substituted 2-pyrrole cyclohexan-1,4-diamine derivatives |
| 10/13/2004 | CN1537093A Novel vinyl carboxylic acid derivatives and their use as antidiabetics etc. |
| 10/13/2004 | CN1537025A 2-(3,5-bis-trifluoromethyl-phenyl)-N-[6-(1.1-dioxo-1 lambda b-thiomorpholin-4-yl)-4-(methyl or 4-fluoro-2-methyl substituted)phenyl-pyridin-3-yl]-N-methyl-isobutyramide |
| 10/13/2004 | CN1537019A Medical combination of aldosterone receptor antagonist and HMG CoA reductase inhibitor |
| 10/13/2004 | CN1537016A Remedies for psychoneurosis |
| 10/13/2004 | CN1537009A Method for treating or preventing functional vitamin B12 dificiency in individual and to medical compositions for use in said method |
| 10/13/2004 | CN1537007A 2 methyl-thieno-benzodiazepine lyophilizde formulation |
| 10/13/2004 | CN1537006A Drug combination for treatment of headache comprising mirtazapine and paracetamol or non-steroidal anti-inflammatory drug |
| 10/13/2004 | CN1537003A Pharmaceutical composition comprising tricyclic compound for prevention or treatment of skin diseases |
| 10/13/2004 | CN1537002A Novel theterocyclic analogs of diphenylethylene compounds |
| 10/13/2004 | CN1537000A Novel imidazolidine derivatives, their preparation and their use as VLA-4 antagonists |
| 10/13/2004 | CN1536997A Crystalline composition containing escitalopram |
| 10/13/2004 | CN1536992A Carbamates of 2-heterocyclic-1, 2-ethanediols |
| 10/13/2004 | CN1536991A (f)-cycloolivil as antioxidant obtained from stereospermum personatum |
| 10/13/2004 | CN1535980A New compound with cativity for inhibiting glycine transport factor |
| 10/13/2004 | CN1535974A Method for producing glucolipid substance using ganglioside as main component |
| 10/13/2004 | CN1535969A Total alkaloid of xiatianwu (a Chinese medicinal material), its preparation method and application |